Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to people with visual disabilities who are using a screen reader; Press Control-F10 to open an accessibility menu.
Experimental COVID-19 Treatment Shows Promise in Clinical Study In a large clinical trial, an experimental COVID-19 treatment called Pegylated Interferon Lambda, prevented 51% of hospitalizations.
Limited COVID-19 Treatment Options Endangers Patients, Particularly Immunocompromised People COVID-19 has adapted to currently available monoclonal antibodies, leaving patients with a limited array of treatments.